Hospital

The observed increase in patient age at the time of relapse makes the findings even more impressive because longer survival is typically associated with younger age at the time of relapse.

Cabotegravir (Apretude) is indicated for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection.

Study results suggest that infection with Epstein-Barr virus may be the leading cause of multiple sclerosis.

C-CAR039 showed positive efficacy and safety data in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

There are many opportunities for pharmacists to hone and overcome their personal discomfort with exercising power and to broaden their repertoire of leadership skills.

Most pharmacists see a transition from transactional care to more direct patient care responsibilities.

Pharmacists should stay abreast of changes in formulations and recommendations, foster communication with their staff, and plan proactively.

Knocking down MAPK4 resulted in the cells’ increased sensitivity to PI3K inhibitors and reduced breast cancer growth.

This high efficacy and low toxicity allow the combination treatment to provide a significant quality-of-life benefit to patients.

Based on the results, the investigators found that a cloth face covering reduced emissions in all directions to about 2 feet compared to the 4 feet of emissions produced when coughing or speaking with no mask on.

Study data showed that increased levels of infection, inflammation, and metabolic alterations frequently observed in people with depression and psychosis may be a cause rather than a consequence of these disorders.

Germ cell tumors that occur in places other than the testicles and ovaries are very rare.

National Pharmacist Day is celebrated each year on January 12 and it is a chance to celebrate the incredible work that pharmacists do for their patients.

In a subset of 537 patients receiving the IV therapy across 178 clinics, there was a 54% response rate and 30% remission rate.

Responses elicited by the pneumococcal vaccine for all 20 serotypes were similar whether administered with the COVID-19 vaccine or with placebo.

Patient engagement can support pharmacists in discovering a wider range of potential drug interactions while promoting medication safety.

Well-designed incentives and education can help address COVID-19 vaccine hesitancy and bolster vaccination rates.

Earlier analyses also demonstrated the same potential of BBV152 against SARS-CoV-2 alpha, beta, delta, zeta, and kappa.

Lefamulin (Xenleta, Nabriva Therapeutics) is approved for the treatment of adults with community-acquired bacterial pneumonia caused by susceptible microorganisms.

Giant cell arteritis frequently causes headaches, scalp tenderness, jaw pain and vision problems.

The FDA granted priority review to the combination of relatlimab and nivolumab in September 2021 based on the results of this study.

Compensation was a positive, while workload, management, and lack of work/life balance are the top reasons for dissatisfaction.

Finding ways to eliminate barriers to care helps narrow the gap.

The data were used to evaluate effect of the ACA state Medicaid on insurance coverage, health care use, and health outcomes measured between 1 month prior to conception through 1 year postpartum, and neonatal outcomes within 27 days of birth.

Ensovibep has met the primary endpoint of viral load reduction over 8 days in a phase 2 study, the companies said.

More aggressive competition and uptake could cause larger cuts, estimated at up to $124.5 billion between 2021 and 2025, according to the results of a RAND corporation analysis.

Ten quiz questions to assess your knowledge on common symptoms and treatments for atrial fibrillation.

Analysis examines the impacted of expected trends in exposure to high blood sugar, low education levels, obesity, and smoking.

Out of the 3959 who were a part of the study, 2403 of the individuals were vaccinated and 1556 were unvaccinated.

About 48% of individuals experienced a complete or partial response when treated with pembrolizumab, and about two-thirds also had a response that lasted more than 3 years.